NORTHERN TRUST CORP - GAIN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.41 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$43,549
-26.8%
13,2770.0%0.00%–
Q2 2023$59,481
-7.1%
13,2770.0%0.00%–
Q1 2023$63,995
+63.0%
13,277
+5.8%
0.00%–
Q4 2022$39,269
-4.2%
12,5460.0%0.00%–
Q3 2022$41,000–12,546–0.00%–
 Download
Other shareholders

There were no reported owners of GAIN THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of GAIN THERAPEUTICS INC shareholders